Companion Diagnostics Market in Asia Pacific is expected to register a CAGR of 21.6% during the forecast period (2019-2025) - KBV Research

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Asia Pacific Companion Diagnostics Market, published by KBV research, the Asia Pacific Companion Diagnostics Market would witness market growth of 21.6% CAGR during the forecast period (2019-2025).

The China market dominated the Asia Pacific Lung Cancer Companion Diagnostics by Country in 2018, growing at a CAGR of 21 % during the forecast period. The Japan market is expected to witness a CAGR of 24.6% during (2019 - 2025). Additionally, The India market is expected to witness a CAGR of 24.6% during (2019 - 2025).

The Oncology market dominated the South Korea Companion Diagnostics Market by Indication in 2018, growing at a CAGR of 23.6 % during the forecast period. The Neurology market is expected to witness a CAGR of 20.7% during (2019 - 2025).

The Polymerase Chain Reaction (PCR) market dominated the Singapore Companion Diagnostics Market by Technology in 2018, growing at a CAGR of 23.7 % during the forecast period. The Immunohistochemistry market is expected to witness a CAGR of 22.5% during (2019 - 2025).

Full Report:https://www.kbvresearch.com/asia-pacific-companion-diagnostics-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, Inc., Almac Group, ARUP Laboratories, Inc., Abbott Laboratories (Abbott Laboratories Molecular, Inc.), Danaher Corporation, Thermo Fisher Scientific, Inc., Hologic, Inc., Novartis AG, Illumina, Inc., Qiagen N.V.

Asia Pacific Companion Diagnostics Market Segmentation

By Technology

  • Immunohistochemistry
  • Polymerase chain reaction (PCR)
  • Next generation sequencing (NGS)
  • In Situ Hybridization and
  • Other Technology

By Indication

  • Oncology
  • Neurology and
  • Other Indications

By Cancer Type

  • Breast Cancer
  • Colorectal Cancer
  • Lung Cancer
  • Blood Cancer and
  • Other Cancer Type

By Country

  • China Companion Diagnostics Market
  • Japan Companion Diagnostics Market
  • India Companion Diagnostics Market
  • South Korea Companion Diagnostics Market
  • Singapore Companion Diagnostics Market
  • Australia Companion Diagnostics Market
  • Rest of Asia Pacific Companion Diagnostics Market

Companies Profiled

  • Agilent Technologies, Inc.
  • Almac Group
  • ARUP Laboratories, Inc.
  • Abbott Laboratories (Abbott Laboratories Molecular, Inc.)
  • Danaher Corporation
  • Thermo Fisher Scientific, Inc.
  • Hologic, Inc.
  • Novartis AG
  • Illumina, Inc.
  • Qiagen N.V.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Companion Diagnostics Market Related Reports:

Global Market

North America Market

Europe Market

LAMEA Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.